This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Sun May 26, 2013 2:20 am

View unanswered posts | View active topics


Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
squiffy2
PostPosted: Fri Apr 20, 2012 3:35 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1689
Image

At the 64th annual meeting of the American Academy of Neurology (AAN) Novartis will present the key results from a phase II dose finding study of its investigational compound BAF312 (siponimod), a selective modulator of the S1P receptor subtypes 1 and 5 (S1P1, 5-R modulator), in MS.

This double-blind placebo-controlled study applied an innovative adaptive trial design to optimally describe the dose response relationship.

A statistically significant dose response relationship could be established....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Fampridine 2 year data positive

scorpion

1

738

Thu Sep 10, 2009 3:28 pm

ElMarino View the latest post

There are no new unread posts for this topic. Positive results from ocrelizumab phase II RRMS study

squiffy2

0

760

Sat Oct 16, 2010 2:37 am

squiffy2 View the latest post

There are no new unread posts for this topic. Positive results - Phase 1B trial of possible MS drug AZ01

squiffy2

0

564

Wed Oct 19, 2011 3:19 am

squiffy2 View the latest post

There are no new unread posts for this topic. Positive top-line results from phase III BOTOX® studies

squiffy2

0

309

Fri Mar 30, 2012 3:16 am

squiffy2 View the latest post

There are no new unread posts for this topic. Additional phase 3 clinical trial data for Ampyra released

squiffy2

0

720

Wed Nov 17, 2010 8:04 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers
This site does not offer, or claim to offer, medical, legal, or professional advice. All treatment decisions should always be made with the full knowledge of your physicians.


All logos and trademarks in this site are property of their respective owners. Content is © 2002-2013 by thisisMS.com.